Allurion Technologies (ALUR) Competitors

Allurion Technologies logo
$5.12 -0.40 (-7.16%)
As of 12:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ALUR vs. NSPR, APT, TMDIF, CTSO, LUCD, APYX, INO, MODD, BLAC, and BDMD

Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include InspireMD (NSPR), Alpha Pro Tech (APT), Titan Medical (TMDIF), Cytosorbents (CTSO), Lucid Diagnostics (LUCD), Apyx Medical (APYX), Inovio Pharmaceuticals (INO), Modular Medical (MODD), Bellevue Life Sciences Acquisition (BLAC), and Baird Medical Investment (BDMD). These companies are all part of the "medical equipment" industry.

Allurion Technologies vs.

Allurion Technologies (NYSE:ALUR) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking.

In the previous week, InspireMD had 4 more articles in the media than Allurion Technologies. MarketBeat recorded 4 mentions for InspireMD and 0 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of 1.00 beat InspireMD's score of 0.11 indicating that Allurion Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Allurion Technologies Positive
InspireMD Neutral

Allurion Technologies received 3 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 87.50% of users gave Allurion Technologies an outperform vote while only 4.55% of users gave InspireMD an outperform vote.

CompanyUnderperformOutperform
Allurion TechnologiesOutperform Votes
7
87.50%
Underperform Votes
1
12.50%
InspireMDOutperform Votes
4
4.55%
Underperform Votes
84
95.45%

21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by insiders. Comparatively, 29.7% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Allurion Technologies has a beta of -0.69, indicating that its share price is 169% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

InspireMD has lower revenue, but higher earnings than Allurion Technologies. InspireMD is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allurion Technologies$53.47M0.27-$80.61M-$12.00-0.47
InspireMD$6.20M12.54-$19.92M-$0.75-3.97

Allurion Technologies has a net margin of -71.24% compared to InspireMD's net margin of -413.96%. Allurion Technologies' return on equity of 0.00% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Allurion Technologies-71.24% N/A -56.75%
InspireMD -413.96%-69.42%-57.68%

Allurion Technologies currently has a consensus target price of $54.17, indicating a potential upside of 870.73%. InspireMD has a consensus target price of $4.75, indicating a potential upside of 59.40%. Given Allurion Technologies' higher probable upside, research analysts plainly believe Allurion Technologies is more favorable than InspireMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allurion Technologies
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Allurion Technologies beats InspireMD on 9 of the 16 factors compared between the two stocks.

Get Allurion Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALUR vs. The Competition

MetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$14.45M$4.84B$5.75B$20.29B
Dividend YieldN/A51.43%5.30%3.68%
P/E Ratio-0.4714.8264.2139.50
Price / Sales0.2756.96998.3816.37
Price / CashN/A50.3946.0620.33
Price / Book-0.156.405.135.80
Net Income-$80.61M$88.65M$113.50M$1.00B
7 Day Performance-12.47%-1.18%-0.51%0.38%
1 Month Performance47.54%1.63%3.88%4.51%
1 Year Performance-91.91%17.74%22.48%17.87%

Allurion Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALUR
Allurion Technologies
2.9888 of 5 stars
$5.13
-7.2%
$54.17
+956.9%
-91.9%$13.27M$53.47M-0.43501Positive News
Gap Up
NSPR
InspireMD
2.7214 of 5 stars
$2.50
-3.1%
$4.75
+90.0%
+8.4%$65.20M$6.20M-3.3350Gap Down
APT
Alpha Pro Tech
N/A$5.30
-0.9%
N/A+6.5%$58.30M$61.23M14.32120Analyst Forecast
TMDIF
Titan Medical
N/A$0.50
flat
N/A+622.6%$57.02M$17.63M-0.4050
CTSO
Cytosorbents
2.6592 of 5 stars
$1.00
-0.5%
$4.67
+366.7%
-2.9%$54.68M$36.35M-2.78220
LUCD
Lucid Diagnostics
3.1303 of 5 stars
$0.91
-5.0%
$3.63
+298.4%
+0.0%$54.00M$2.43M-0.8070
APYX
Apyx Medical
1.2414 of 5 stars
$1.42
-1.4%
N/A-43.3%$53.45M$52.35M-1.71270Positive News
INO
Inovio Pharmaceuticals
3.857 of 5 stars
$1.99
-4.8%
$12.40
+523.1%
-71.5%$51.94M$830,000.000.00320News Coverage
Gap Down
MODD
Modular Medical
2.7265 of 5 stars
$1.27
-0.8%
$5.00
+293.7%
-22.1%$51.65MN/A-2.0220
BLAC
Bellevue Life Sciences Acquisition
N/A$11.31
-0.4%
N/AN/A$45.69MN/A0.00N/AGap Down
BDMD
Baird Medical Investment
N/A$6.74
-4.9%
N/AN/A$44.35MN/A0.00N/AGap Down

Related Companies and Tools


This page (NYSE:ALUR) was last updated on 2/11/2025 by MarketBeat.com Staff
From Our Partners